Business Description
Proteome Sciences PLC
ISIN : GB0003104196
Description
Proteome Sciences PLC is protein biomarker research and development. provider of contract research services for the identification, validation and application of protein biomarkers. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Other.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.09 | |||||
| Equity-to-Asset | -0.56 | |||||
| Debt-to-Equity | -2.59 | |||||
| Debt-to-EBITDA | -5.37 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -9.39 | |||||
| Beneish M-Score | -3.24 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 3.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 78.55 | |||||
| 9-Day RSI | 60.88 | |||||
| 14-Day RSI | 53.37 | |||||
| 6-1 Month Momentum % | -32.98 | |||||
| 12-1 Month Momentum % | -25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | |||||
| Quick Ratio | 0.14 | |||||
| Cash Ratio | 0.09 | |||||
| Days Inventory | 77.65 | |||||
| Days Sales Outstanding | 55.6 | |||||
| Days Payable | 54.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -19.28 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 2.11 | |||||
| Operating Margin % | -78.41 | |||||
| Net Margin % | -101.07 | |||||
| FCF Margin % | -52.62 | |||||
| ROA % | -38.22 | |||||
| ROIC % | -17.45 | |||||
| ROC (Joel Greenblatt) % | -102.73 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.63 | |||||
| EV-to-EBIT | -7.11 | |||||
| EV-to-EBITDA | -8.87 | |||||
| EV-to-Revenue | 5.58 | |||||
| EV-to-FCF | -10.55 | |||||
| Price-to-Median-PS-Value | 0.69 | |||||
| Earnings Yield (Greenblatt) % | -14.06 | |||||
| FCF Yield % | -21.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Proteome Sciences PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4.73 | ||
| EPS (TTM) (€) | -0.016 | ||
| Beta | -0.5 | ||
| Volatility % | 97.03 | ||
| 14-Day RSI | 53.37 | ||
| 14-Day ATR (€) | 0.001245 | ||
| 20-Day SMA (€) | 0.02575 | ||
| 12-1 Month Momentum % | -25 | ||
| 52-Week Range (€) | 0.0185 - 0.058 | ||
| Shares Outstanding (Mil) | 295.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Proteome Sciences PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Proteome Sciences PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Proteome Sciences PLC Frequently Asked Questions
What is Proteome Sciences PLC(FRA:PI2)'s stock price today?
The current price of FRA:PI2 is €0.03. The 52 week high of FRA:PI2 is €0.06 and 52 week low is €0.02.
When is next earnings date of Proteome Sciences PLC(FRA:PI2)?
The next earnings date of Proteome Sciences PLC(FRA:PI2) is 2025-04-10 Est..
Does Proteome Sciences PLC(FRA:PI2) pay dividends? If so, how much?
Proteome Sciences PLC(FRA:PI2) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers